Krämer, A., Bochtler, T., Pauli, C., Shiu, K., Cook, N., Menezes, J. J. d., . . . Mileshkin, L. (2024). Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): An open-label, randomised, phase 2 study. The lancet, 404(10452), . https://doi.org/10.1016/S0140-6736(24)00814-6
Chicago-Zitierstil (17. Ausg.)Krämer, Alwin, et al. "Molecularly Guided Therapy Versus Chemotherapy After Disease Control in Unfavourable Cancer of Unknown Primary (CUPISCO): An Open-label, Randomised, Phase 2 Study." The Lancet 404, no. 10452 (2024). https://doi.org/10.1016/S0140-6736(24)00814-6.
MLA-Zitierstil (9. Ausg.)Krämer, Alwin, et al. "Molecularly Guided Therapy Versus Chemotherapy After Disease Control in Unfavourable Cancer of Unknown Primary (CUPISCO): An Open-label, Randomised, Phase 2 Study." The Lancet, vol. 404, no. 10452, 2024, https://doi.org/10.1016/S0140-6736(24)00814-6.